Literature DB >> 1390234

Myelodysplastic syndromes in childhood: a population based study of nine cases.

H Hasle1, B B Jacobsen, N T Pedersen.   

Abstract

Nine cases of de novo myelodysplastic syndromes (MDS) in childhood from a population based study are presented. The annual incidence of MDS was 3.4/1,000,000 in children less than 15 years old, corresponding to 8.7% of all haematological malignancies in childhood. Two patients had Down's syndrome. None of the remaining patients had constitutional anomalies. All patients were classified according to the FAB classification. Five patients presented with refractory anaemia (RA), only one of these did not progress, one showed clonal evolution, and the remaining three patients all progressed to refractory anaemia with excess of blasts (RAEB). Three patients presented with RAEB. Two progressed to overt leukaemia. The last patient was classified as chronic myelomonocytic leukaemia (CMML). Clonal cytogenetic abnormalities were detected in five patients, in three of them as monosomy 7. Five patients have died; two of progressive disease, two of infections, and one of haemorrhage, two of the latter three patients died during therapy induced cytopenia. Of the four patients still alive, one patient showed a complete remission after cyclosporine and later immunoglobulin therapy, one patient is a long-term survivor after allogeneic bone marrow transplantation, and one patient apparently obtained a spontaneous remission several months after chemotherapy.

Entities:  

Mesh:

Year:  1992        PMID: 1390234     DOI: 10.1111/j.1365-2141.1992.tb02980.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Myelodysplasia in children.

Authors:  Urmila N Khadilkar; Jyostna P Dayal
Journal:  Indian J Pediatr       Date:  2002-04       Impact factor: 1.967

2.  Cytogenetics and clinical features of pediatric myelodysplastic syndrome in Japan.

Authors:  Koichi Moriwaki; Atsushi Manabe; Takeshi Taketani; Akira Kikuchi; Tatsutoshi Nakahata; Yasuhide Hayashi
Journal:  Int J Hematol       Date:  2014-09-27       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.